HROW Q2 2018 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q2 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$10M+51.4% YoY

Gross Profit

$6M60.0% margin

Operating Income

-$624,000-6.0% margin

Net Income

$3M24.3% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

+17.1%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

$929,000

Stock-Based Comp.

$608,000

Balance Sheet

Total Assets

$26M

Total Liabilities

$23M

Stockholders' Equity

$4M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$7M	+51.4%
Gross Profit	$6M	$4M	+74.5%
Operating Income	-$624,000	-$3M	+79.3%
Net Income	$3M	$1M	+69.9%

Revenue Segments

Product Sales, Net

$10M100%

License Revenues

$10,0000%